NICE Guidelines December 2020
There have been eight guidelines, two COVID-19 rapid guidelines and one technology appraisal published in December 2020 by the National Institute for Clinical Excellence which has impact upon primary care.
The COVID-19 rapid guideline: managing the long -term effects of COVID-19 guideline has been published. The guideline covers identifying, assessing and managing the long-term effects of COVID-19, often referred to as ‘long COVID’.
The COVID-19 rapid guideline: vitamin D guideline has been published. The guideline covers vitamin D use in the context of COVID-19. It is for adults, young people and children in hospitals and community settings.
The Liraglutide for managing overweight and obesity technology appraisal has been published. The prescribing is restricted to secondary care by a specialist multidisciplinary tier 3 weight management service with a commercial agreement in place.
The Osteoarthritis: care and management guideline, Low back pain and sciatica in over 16s: assessment and management guideline and the Peripheral arterial disease: diagnosis and management guideline have both been updated in line with guidance on the use of opioids for non-cancer pain in response to a Public Health England evidence review on dependence on, and withdrawal from, prescribed medicines.
The Pancreatitis guideline and the Eating disorders: recognition and treatment guideline have both been updated in line with MHRA advice highlighting the importance of rotating insulin injection sites within the same body region.
The Type 1 diabetes in adults: diagnosis and management guideline and the Type 2 diabetes in adults: management guideline have both seen minor changes to the recommendations on diabetic retinopathy to align them with the NHS diabetic eye screening programme.
The Diabetes in pregnancy: management from preconception to the postnatal period guideline has seen changed recommendations on intermittently scanned CGM (isCGM, also commonly referred to as flash) and continuous glucose monitoring during pregnancy for women with type 1 diabetes.
Clinicians should be aware of these guidelines and implement any necessary changes to their practice.
NICE Guidelines November 2020
There has been one guideline published in November 2020 by the National Institute for Clinical Excellence which has impact upon primary care.
The Human and animal bites: antimicrobial prescribing guideline has been updated and published. The guideline sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over.
Clinicians should be aware of this guideline and implement any necessary changes to their practice.
CKS Updates November 2020
During the month of November 2020, the following Clinical Knowledge Summaries were published or updated:
All the above topics have been reviewed and updated in line with NICE guidance with minor layout changes. The Menopause topic includes a lower age range of 35 to include the diagnosis and management of suspected premature ovarian insufficiency. Further information on non-hormonal therapy for the management of vasomotor symptoms and women with hypothyroidism, has been added to the section on managing co-morbidities.
Clinicians can use the updated and new information when reviewing patients.
The information in the Prescribing News section has been adapted from the Prescribing Advice for GPs blog
This section has been adapted from www.prescriber.org.uk